Tolerability, Safety, and Activity of SRX246 in Irritable Subjects With Huntington’s Disease
Condition(s):Irritable Mood; Huntington’s DiseaseLast Updated:July 20, 2023Completed
Hide Studies Not Open or Pending
Condition(s):Irritable Mood; Huntington’s DiseaseLast Updated:July 20, 2023Completed
Condition(s):Huntington’s DiseaseLast Updated:September 17, 2021Terminated
Condition(s):Huntington’s DiseaseLast Updated:May 2, 2022Completed
Condition(s):Huntington DiseaseLast Updated:January 7, 2020Completed
Condition(s):Huntington DiseaseLast Updated:August 25, 2021Completed
Condition(s):Frontotemporal Dementia; Huntington Disease; Alzheimer Disease; Semantic Dementia; Dementia, VascularLast Updated:July 20, 2020Completed
Condition(s):Parkinson Disease; Huntington DiseaseLast Updated:December 5, 2016Completed
Condition(s):Alzheimer’s Disease; Amyotrophic Lateral Sclerosis; Brain Injury; Huntington’s Disease; Multiple Sclerosis; Parkinson’s Disease; Stroke; Spinal Cord InjuryLast Updated:September 26, 2018Completed
Condition(s):Parkinson Disease; Huntington DiseaseLast Updated:December 22, 2023Completed
Condition(s):Huntington DiseaseLast Updated:February 5, 2020Completed
At TrialBulletin.com, we keep tabs on over 200,000 clinical trials in the US and abroad, using medical data supplied directly by the US National Institutes of Health. Please see the About and Contact page for details.